A case of extramammary Paget's disease treated with 5% imiquimod cream
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, M.H. | - |
dc.contributor.author | Jeon, J.H. | - |
dc.contributor.author | Son, S.W. | - |
dc.contributor.author | Kim, I.H. | - |
dc.date.accessioned | 2021-09-09T18:06:44Z | - |
dc.date.available | 2021-09-09T18:06:44Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2006 | - |
dc.identifier.issn | 0494-4739 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/126012 | - |
dc.description.abstract | Extramammary Paget's disease (EMPD) is a rare intraepidermal adenocarcinoma. Mohs micrographic surgery is considered the standard treatment. Other treatment modalities such as surgical excision, radiotherapy, topical chemotherapy, and photodynamic therapy are associated with varying degrees of effectiveness, and possible loss of tissue function and disease recurrence are seen. The search for an effective, safe treatment with minimal side effects proves to be challenging. Imiquimod is the first representative of a new class of immunomodulating drugs demonstrating potent antiviral and antitumor activity, and has been approved by the FDA for treating anogenital warts, actinic keratosis and basal cell carcinoma. Recent research has demonstrated its effective usage as a 5% cream in the management of EMPD. We report a case of EMPD of the scrotum successfully treated with topical 5% imiquimod cream. This has never been published in the Korea dermatologic literature. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.subject | imiquimod | - |
dc.subject | immunomodulating agent | - |
dc.subject | antineoplastic activity | - |
dc.subject | article | - |
dc.subject | cancer chemotherapy | - |
dc.subject | cancer radiotherapy | - |
dc.subject | cancer surgery | - |
dc.subject | case report | - |
dc.subject | drug activity | - |
dc.subject | drug mechanism | - |
dc.subject | drug tolerance | - |
dc.subject | human | - |
dc.subject | Paget skin disease | - |
dc.subject | photodynamic therapy | - |
dc.title | A case of extramammary Paget's disease treated with 5% imiquimod cream | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jeon, J.H. | - |
dc.identifier.scopusid | 2-s2.0-33745046691 | - |
dc.identifier.bibliographicCitation | Korean Journal of Dermatology, v.44, no.3, pp.365 - 368 | - |
dc.relation.isPartOf | Korean Journal of Dermatology | - |
dc.citation.title | Korean Journal of Dermatology | - |
dc.citation.volume | 44 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 365 | - |
dc.citation.endPage | 368 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | imiquimod | - |
dc.subject.keywordPlus | immunomodulating agent | - |
dc.subject.keywordPlus | antineoplastic activity | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | cancer chemotherapy | - |
dc.subject.keywordPlus | cancer radiotherapy | - |
dc.subject.keywordPlus | cancer surgery | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | drug activity | - |
dc.subject.keywordPlus | drug mechanism | - |
dc.subject.keywordPlus | drug tolerance | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | Paget skin disease | - |
dc.subject.keywordPlus | photodynamic therapy | - |
dc.subject.keywordAuthor | Extramammary Paget&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | Imiquimod | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.